Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Stivarga also improved survival in those with recurrent HCC after a liver transplant.
Cabometyx is the third liver cancer drug approved in the past six months.
Recommendations now include multiple systemic medications in addition to surgery and local therapies.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.